SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-073985
Filing Date
2024-03-21
Accepted
2024-03-21 17:14:35
Documents
14
Period of Report
2024-03-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d798181d8k.htm   iXBRL 8-K 23766
2 EX-99.1 d798181dex991.htm EX-99.1 50321
  Complete submission text file 0001193125-24-073985.txt   208870

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA tsbx-20240321.xsd EX-101.SCH 2865
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tsbx-20240321_lab.xml EX-101.LAB 18737
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tsbx-20240321_pre.xml EX-101.PRE 11717
17 EXTRACTED XBRL INSTANCE DOCUMENT d798181d8k_htm.xml XML 3769
Mailing Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010
Business Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

IRS No.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41747 | Film No.: 24772311
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)